XBiotech (XBIT) Shares Outstanding (2014 - 2026)
XBiotech (XBIT) posted Shares Outstanding (Entity) of $30.5 million for Q2 2026, little changed on a QoQ basis from $30.5 million in Q4 2025, and little changed year-over-year from $30.5 million in Q2 2025.
Analysis
XBiotech (XBIT) Shares Outstanding (2014 - 2026) Analysis & Trends
XBiotech has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $30.5 million in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) changed 0.0% year-over-year to $30.5 million in Q2 2026; TTM through Jun 2026 was $30.5 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $30.5 million, changed 0.0% from the prior year.
- Shares Outstanding (Entity) was $30.5 million for Q2 2026 at XBiotech, roughly flat from $30.5 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $30.5 million in Q4 2024, with the low at $30.4 million in Q2 2023.
- Average Shares Outstanding (Entity) over 5 years is $30.5 million, with a median of $30.5 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) increased 1.52% in 2022, then decreased 0.01% in 2023.
- Over 5 years, Shares Outstanding (Entity) stood at $30.4 million in 2022, then fell by 0.01% to $30.4 million in 2023, then climbed by 0.17% to $30.5 million in 2024, then changed by 0.0% to $30.5 million in 2025, then changed by 0.0% to $30.5 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $30.5 million (Q2 2026), $30.5 million (Q4 2025), and $30.5 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 540.00 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 253.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 61.30 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 398.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 147.70 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 720.78 Mn |
| 10 | XBiotech | 66.16 Mn | 66.16 Mn | - | 30.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.49 Mn |
| Dec 31, 2025 | 30.49 Mn |
| Sep 30, 2025 | 30.49 Mn |
| Jun 30, 2025 | 30.49 Mn |
| Mar 31, 2025 | 30.49 Mn |
| Dec 31, 2024 | 30.46 Mn |
| Sep 30, 2024 | 30.47 Mn |
| Jun 30, 2024 | 30.46 Mn |
| Mar 31, 2024 | 30.44 Mn |
| Dec 31, 2023 | 30.44 Mn |
| Sep 30, 2023 | 30.44 Mn |
| Jun 30, 2023 | 30.44 Mn |
| Mar 31, 2023 | 30.44 Mn |
| Dec 31, 2022 | 30.44 Mn |
| Sep 30, 2022 | 30.44 Mn |
| Jun 30, 2022 | 30.44 Mn |
| Mar 31, 2022 | 30.04 Mn |
| Dec 31, 2021 | 30.04 Mn |
| Sep 30, 2021 | 30.34 Mn |
| Jun 30, 2021 | 29.99 Mn |